BBB permeability of the compounds was investigated by using a PAMPA method (parallel artificial membrane permeability assay). The PAMPA system consisted of a 96-well microfilter plate and a 96-well filter plate and was divided into two chambers: a donor at the bottom and an acceptor at the top, separated by a 120-μm-thick microfilter disc coated with BBB lipid solution (Pion, Inc.). The solutions of each compound were prepared in dimethyl sulfoxide (DMSO) at 4 mg/mL concentration and then diluted with Prisma buffer (pH = 7.4) to obtain the donor drug solution with the final nominal concentration of 20 µg/mL. The donor solutions were placed on the donor plate. Acceptor plate contained Brain Sink Buffer (BSB). The plates were put together and incubated at 37 °C for 180 min in a humidity-saturated atmosphere. The concentrations of the compounds were determined with a UV-reader (Multiskan GO, Thermo Scientific) at 254 nm in the donor and acceptor compartments.
The permeability values (Pe) were calculated by using the following equation:
where VD: donor volume, VA: acceptor volume, Cequilibrium: equilibrium concentration CD: donor concentration, CA: acceptor concentration, S: membrane area, and t: incubation time (in seconds). High BBB permeation (CNS+) was expected for compounds with Pe > 5.19, whereas low BBB permeation (CNS-) was expected for compounds with Pe < 2.07 [21].
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.